Swetha Srinivasan

683 total citations
9 papers, 463 citations indexed

About

Swetha Srinivasan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Swetha Srinivasan has authored 9 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Swetha Srinivasan's work include Extracellular vesicles in disease (2 papers), CAR-T cell therapy research (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Swetha Srinivasan is often cited by papers focused on Extracellular vesicles in disease (2 papers), CAR-T cell therapy research (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Swetha Srinivasan collaborates with scholars based in United States, Austria and Australia. Swetha Srinivasan's co-authors include J. Brandon Dixon, Fredrik Vannberg, Charles A. Staley, David A. Kooby, Keith A. Delman, Abbas Chamsuddin, Vasili Egnatashvili, Hyun S. Kim, John Kauh and S Sitaraman and has published in prestigious journals such as Scientific Reports, European Journal of Cancer and Transplantation.

In The Last Decade

Swetha Srinivasan

7 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swetha Srinivasan United States 4 161 141 98 83 76 9 463
Weixin Niu China 14 161 1.0× 110 0.8× 312 3.2× 17 0.2× 96 1.3× 25 622
Minshan Chen China 10 109 0.7× 205 1.5× 121 1.2× 8 0.1× 125 1.6× 37 480
Masaya Shito Japan 11 56 0.3× 171 1.2× 296 3.0× 69 0.8× 71 0.9× 21 451
Anweshan Samanta United States 9 220 1.4× 57 0.4× 282 2.9× 11 0.1× 49 0.6× 25 679
G. Pott Germany 11 68 0.4× 105 0.7× 70 0.7× 19 0.2× 99 1.3× 37 325
Rita Lippai Hungary 9 84 0.5× 33 0.2× 54 0.6× 13 0.2× 50 0.7× 10 339
Hisayuki Fukutomi Japan 13 104 0.6× 19 0.1× 295 3.0× 81 1.0× 42 0.6× 38 593
Gino T.P. Saccone Australia 16 132 0.8× 15 0.1× 456 4.7× 75 0.9× 77 1.0× 50 772
Osamu Aramaki Japan 17 89 0.6× 215 1.5× 425 4.3× 9 0.1× 134 1.8× 70 866

Countries citing papers authored by Swetha Srinivasan

Since Specialization
Citations

This map shows the geographic impact of Swetha Srinivasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swetha Srinivasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swetha Srinivasan more than expected).

Fields of papers citing papers by Swetha Srinivasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swetha Srinivasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swetha Srinivasan. The network helps show where Swetha Srinivasan may publish in the future.

Co-authorship network of co-authors of Swetha Srinivasan

This figure shows the co-authorship network connecting the top 25 collaborators of Swetha Srinivasan. A scholar is included among the top collaborators of Swetha Srinivasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swetha Srinivasan. Swetha Srinivasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kirkwood, John M., Peter Mohr, Christoph Höeller, et al.. (2025). Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trial. European Journal of Cancer. 220. 115371–115371.
2.
Moser, Justin C., Shailender Bhatia, Asim Amin, et al.. (2024). Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data. Cancer Immunology Immunotherapy. 73(7). 116–116. 1 indexed citations
3.
Perper, Stuart J., Susan V. Westmoreland, Swetha Srinivasan, et al.. (2024). Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease. ACR Open Rheumatology. 6(12). 900–911.
4.
Osazuwa‐Peters, Oyomoare L., Lauren E. Wilson, Devon K. Check, et al.. (2023). Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer. Clinical Lung Cancer. 24(4). 305–312. 2 indexed citations
5.
Srinivasan, Swetha, Manuel Duval, Vivek Kaimal, Carolyn A. Cuff, & Stephen H. Clarke. (2019). Assessment of methods for serum extracellular vesicle small RNA sequencing to support biomarker development. Journal of Extracellular Vesicles. 8(1). 1684425–1684425. 19 indexed citations
6.
Srinivasan, Swetha, Fredrik Vannberg, & J. Brandon Dixon. (2016). Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node. Scientific Reports. 6(1). 24436–24436. 136 indexed citations
7.
Chandrasekharan, Bindu, Mallappa Anitha, Nikrad Shahnavaz, et al.. (2010). Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterology & Motility. 23(2). 131–e26. 151 indexed citations
9.
Kooby, David A., Vasili Egnatashvili, Swetha Srinivasan, et al.. (2009). Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 21(2). 224–230. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026